Compared to Estimates, Aquestive Therapeutics (AQST) Q1 Earnings: A Look at Key Metrics

Aquestive Therapeutics (AQST) reported $12.05 million in revenue for the quarter ended March 2024, representing a year-over-year increase of 8.3$0.17 for the same period compares to $0.11 a year ago. The reported revenue represents a surprise of -1.37$12.22 million. With the consensus EPS estimate being -$0.09, the EPS surprise was -88.89%. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectatio ...